From Innovation to Impact: INDIA'S LIFE SCIENCES ROADMAP ΤΟ 2047

As India moves steadily towards the milestone of its centenary year of Independence in 2047, the life sciences sector is emerging as one of the most critical engines of national growth.

- 

From biotechnology and pharmaceuticals to diagnostics, medtech, and advanced therapies, the sector is expected to play a defining role in shaping India’s healthcare outcomes, economic resilience, and global competitiveness. Against this backdrop, a high-level panel discussion titled “Transforming India into a Life Sciences Powerhouse: Journey Ahead into 2047!” brought together key stakeholders to examine what it will take for India to realise this ambition.

A Strategic Vision Rooted in Deep Science

Setting the tone for the discussion,

Dr Jitendra Kumar, Managing Director, Biotechnology Industry Research Assistance Council (BIRAC) emphasised that India's aspiration to become a global life sciences powerhouse must be rooted in deep science, long-term policy vision, and institutional capability building. While India has made significant progress over the past decade in nurturing biotech startups and innovation-led enterprises, he noted that the next phase of growth would require a shift from volume-driven expansion to science-led value creation.

Dr Kumar highlighted the transformative potential of artificial intelligence (AI) across the life sciences value chain, particularly in drug discovery, protein structure prediction, cell and gene therapy, genome editing technologies such as CRISPR, and precision medicine. However, he cautioned that Al adoption must go beyond surface-level applications and pilot projects.